$2.37B
$599,000
0.0% of portfolio
43,826
Q1 2025
Added 67.43%
$1.46B
$484,000
0.0% of portfolio
6,508
Q3 2025
Reduced 31.08%
$13.5B
$1.32 Million
0.0% of portfolio
15,481
Q3 2025
Added 0.19%
-
$0
0.0% of portfolio
-
Q3 2025
Added 5.27%
$5.23B
$394,000
0.0% of portfolio
1,797
Q1 2025
Reduced 19.16%
$2.57B
$284,000
0.0% of portfolio
5,105
Q4 2024
Added 2.1%
$1.56B
$352,000
0.0% of portfolio
5,898
Q3 2025
Added 0.07%
-
$0
0.0% of portfolio
-
Q1 2021
New
$1.09B
$160,000
0.0% of portfolio
10,000
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 31.2%
$2.95B
$743,000
0.0% of portfolio
24,232
Q3 2025
Added 70.3%
$121M
$394,000
0.0% of portfolio
249,838
Q3 2025
Added 5.19%
$44.3B
$429,000
0.0% of portfolio
47,834
Q3 2025
Added 5.78%
$2.01B
$393,000
0.0% of portfolio
14,293
Q3 2025
New
$42.6B
$1.3 Million
0.0% of portfolio
9,769
Q3 2025
Added 13.46%
$10.7B
$1.14 Million
0.0% of portfolio
15,014
Q3 2025
Added 4.03%
$3.35B
$435,000
0.0% of portfolio
28,830
Q3 2025
Added 9.0%
$68.4B
$690,000
0.0% of portfolio
20,223
Q3 2025
Added 146.05%
$10.2B
$275,000
0.0% of portfolio
14,547
Q3 2025
Added 32.58%
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.5%
$12B
$435,000
0.0% of portfolio
2,925
Q3 2025
Reduced 3.08%
$9.72B
$550,000
0.0% of portfolio
8,289
Q3 2025
Reduced 4.34%
$0
$20,000
0.0% of portfolio
5,602
Q4 2023
Reduced 0.11%
$1.89B
$67,000
0.0% of portfolio
9,932
Q2 2025
Reduced 1.0%
$29.4B
$1.34 Million
0.0% of portfolio
54,633
Q3 2025
Added 7.5%
$5.82B
$354,000
0.0% of portfolio
5,659
Q3 2025
Added 46.0%
$72.9B
$560,000
0.0% of portfolio
2,160
Q3 2025
Added 1.12%
$7.35B
$1.22 Million
0.0% of portfolio
21,518
Q3 2025
Reduced 1.13%
$454M
$47,000
0.0% of portfolio
15,050
Q3 2025
Reduced 31.28%
-
$0
0.0% of portfolio
-
Q1 2025
Added 157.53%
$703M
$499,000
0.0% of portfolio
31,200
Q4 2023
Reduced 2.5%
$12.6B
$246,000
0.0% of portfolio
14,478
Q3 2025
Added 7.87%
$8.94B
$251,000
0.0% of portfolio
1,223
Q3 2025
New
$25.4B
$844,000
0.0% of portfolio
30,998
Q3 2025
Reduced 77.96%
$284B
$740,000
0.0% of portfolio
10,432
Q3 2025
Reduced 3.99%
$1.16B
$482,000
0.0% of portfolio
13,998
Q3 2025
Reduced 4.92%
$23.2B
$1.49 Million
0.0% of portfolio
3,460
Q3 2025
Reduced 84.3%
$19B
$334,000
0.0% of portfolio
715
Q3 2025
Reduced 26.29%
$30B
$1.14 Million
0.0% of portfolio
4,380
Q3 2025
Reduced 2.54%
$16.9B
$428,000
0.0% of portfolio
3,191
Q3 2025
Reduced 23.86%
$12.5B
$726,000
0.0% of portfolio
2,523
Q3 2025
Added 84.43%
$6.49B
$307,000
0.0% of portfolio
2,328
Q3 2025
Added 0.26%
$12.4B
$583,000
0.0% of portfolio
3,584
Q3 2025
Reduced 3.06%
$7.49B
$208,000
0.0% of portfolio
525
Q3 2025
New
$19B
$285,000
0.0% of portfolio
3,002
Q3 2025
Added 16.09%
$833M
$590,000
0.0% of portfolio
240,214
Q3 2025
Added 0.17%
$161M
$33,000
0.0% of portfolio
18,569
Q3 2025
New
$3.15B
$218,000
0.0% of portfolio
3,157
Q3 2025
New
$30.4B
$1.19 Million
0.0% of portfolio
14,411
Q3 2025
Reduced 1.1%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 2.55%